IRMS at St. Barnabas — Livingston, New Jersey

IRMS at St. Barnabas is a clinical research site located in Livingston, New Jersey, United States 07078.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

IRMS at St. Barnabas has participated in 1 clinical trials.

Therapeutic areas: Infertility, Aneuploidy.

Sponsors: Illumina, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Livingston

Browse all research sites in New Jersey · View every site in Livingston

• Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey)
• Saint Barnabas Medical Center
• Cooperman Barnabas Medical Center
• St Barnabas Medical Center
• Research Site
• St. Barnabas Medical Center Cancer Center
• Novartis Investigative Site
• Institute of Neurology and Neurosurgery at Saint Barnabas
• Pfizer Investigational Site
• St. Barnabas Cancer Center
• St. Barnabas Health Care Sys
• St. Barnabas

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for IRMS at St. Barnabas?

IRMS at St. Barnabas has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has IRMS at St. Barnabas conducted?

IRMS at St. Barnabas has 1 clinical trials on record. Their work covers Infertility, Aneuploidy.

Is IRMS at St. Barnabas accredited by Crixeo Clinical Trials?

IRMS at St. Barnabas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about IRMS at St. Barnabas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.